Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15741443 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: ICS+LABA;   Other: routine therapy
2 Recruiting Bacteriology and Inflammation in Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Fluroquinolones;   Drug: Beta-lactamase inhibitor

Study has passed its completion date and status has not been verified in more than two years.